Unimed has acquired Elssi Maritime Services to enhance its maritime health and compliance offerings, supported by ZCG Private Equity.
Information on the Target
Universal Maritime Solutions ("Unimed"), a leading global provider of medical and compliance solutions for the maritime industry, has acquired Elssi Maritime Services ("Elssi"), a premier provider of drug and alcohol testing services based in Greece and Cyprus. Founded in 1993, Elssi has established itself as one of the most trusted partners for high-standard drug and alcohol testing within the international shipping community. Beyond its core services, Elssi also offers a comprehensive array of testing capabilities, including drinking water analysis and benzene testing.
This acquisition aims to incorporate Elssi's specialized testing services into Unimed’s award-winning technology platform, which was recently recognized with the 2025 SAFETY4SEA Technology Award for its Medscale Digital Platform. The integration will enable clients to seamlessly access compliance tools, reporting, and health services in a single, streamlined digital experience, significantly enhancing Unimed’s global maritime compliance solutions.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Greece and Cyprus
Greece and Cyprus are vital hubs for international shipping, collectively home to a significant percentage of the world’s merchant fleet. The maritime industry in these countries has been characterized by its robust regulatory framework, ensurin
Similar Deals
Universal Maritime Solutions (Unimed) → Elssi Maritime Services
2025
Gannet BioChem → Laysan Bio
2026
Universal Maritime Solutions
invested in
Elssi Maritime Services
in 2025
in a Other deal